Schedule 13G ownership disclosure

BIOTECH ACQUISITION COMPANY

Security class unavailable · CUSIP: G1125A108

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,261,609
Percent of class
5.4900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001393825-23-000011
Form type
SC 13G
Filer
Biotech Acquisition Co
CIK
CIK 1825413
Filed
Jan 25, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub